Abstract
In a very short time, the Coronavirus disease (COVID-19) caused by the SARS-CoV-2 virus, has become a global pandemic. It has infected about 29,155,581 patients and brought forth death rate about 926,544 among 216 countries as recorded by World Health Organization on 15th September 2020. At present, there is no specific and direct treatment or vaccine for this infectious disease. No therapeutic options available to cure the infection in till date which increases the mortality rate across the countries. Currently there is no antiviral treatments have been approved, several approaches have been proposed in western medicine, Chinese medicine, CAM, AYUSH and other systems. Siddha Herbal medicines are achieving high attention because of the extensive therapeutics like potent anti-microbial, immunomodulatory, anti-inflammatory, and antioxidant properties. Ministry of AYUSH, Govt. of India recommended 12 Siddha herbals (Inji – Zingiber officinale, Thulasi – Ocimum sanctum, Milaku – Piper nigrum, Karunjeeragam – Nigella sativa, Keezhanelli – Phyllanthus niruri, Adhimathuram – Glycyrrhiza glabra, Vellaippoondu – Allium sativum, Citramutti – Sida cardifolia, Seenthil – Tinospora cordifolia, Manjal – Curcuma longa, Elumitchai – Citrus lemon and Vembu – Azadirachta indica) for the prevention by enhancing immunity as well as for the management of this infectious disease in its recent official publication ‘Guidelines for Siddha Practitioners for COVID 19’. This is the common advisory and the anti-viral activity of these herbals against COVID 19 is not established yet. The current situation demands proper herbal drug utilization to prepare the population immunity to fight against the infection. The present review spotlight on the literature review and the review of pharmacological actions of these herbals.
Highlights
Coronavirus Disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV), which was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China [1]
WHO declared the COVID - 19 outbreaks a global health emergency on 30th January 2020 [3, 4] and global pandemic on 11th March 2020 [5]. This global pandemic in a short time has infected about 29,155,581 patients and brought forth death rate about 926,544 among 216 countries as mentioned by World Health Organization on 15th September 2020 [6]
In this review, mentioned herbals are being prescribed for acute respiratory infectious diseases and other chronic respiratory diseases in Siddha System of Medicine from ancient times
Summary
Coronavirus Disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV), which was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China [1]. As per the Siddha literature tamil quote ‘ver paaru thazhai paaru minjinakkaal parpa chenduram paarae’, herbal medicines are the first choice of drugs for all diseases in SSM, if satisfied result not occurs with herbal ingredients, higher order medicines prepared from Metal and Mineral, and from Marine products are prescribed. This emphasizes the usage and importance of Herbals in SSM [9]. This guideline recommended Siddha herbs for the prevention by enhancing immunity as well as for the management of this infectious disease which are being prescribed for acute viral and bacterial respiratory diseases and other chronic respiratory diseases in SSM from ancient times. The author made attempt to discuss the literature review and the review of pharmacological actions of these herbals in this article
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.